Study Summary: This study looks at a new medicine, BA3071, to see if it is safe and works well for people with solid tumors. Solid tumors are lumps of cancer cells that grow in the body. Researchers want to learn about side effects, how the body processes the medicine (called pharmacokinetics or PK), and if it helps fight cancer.
People who can join must be adults (18+), have a type of cancer that can be measured, and be healthy enough for certain physical activities. They can't have certain heart problems or infections like HIV or hepatitis. Women who are pregnant or breastfeeding cannot join.
Key Points:
- This study takes place in multiple centers and is open to new participants now.
- Participants must not have had major surgery recently or severe allergic reactions to similar medicines.
- Participants will be checked for specific genetic mutations, such as KRAS and STK11, to see if they are eligible.
How understandable was the trial content above?
Hard to understand
Easy to understand